Authors:
SMAILL JB
DENNY WA
FRY DW
NELSON JM
LEOPOLD WR
VINCENT PW
HOOK KE
ELLIOTT WL
BRIDGES AJ
ZHOU H
SHOWALTER HDH
MCNAMARA DJ
DOBRUSIN EM
Citation: Jb. Smaill et al., DEVELOPMENT OF IRREVERSIBLE EGFR TYROSINE KINASE INHIBITORS WITH ANTITUMOR-ACTIVITY AGAINST HUMAN TUMOR XENOGRAFTS, Annals of oncology, 9, 1998, pp. 415-415
Authors:
REWCASTLE GW
MURRAY DK
ELLIOTT WL
FRY DW
HOWARD CT
NELSON JM
ROBERTS BJ
VINCENT PW
SHOWALTER HDH
WINTERS RT
DENNY WA
Citation: Gw. Rewcastle et al., TYROSINE KINASE INHIBITORS - 14 - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR METHYLAMINO-SUBSTITUTED DERIVATIVES OF ENYL)AMINO]-6-(METHYLAMINO)PYRIDO[3,4-D]PYRIMIDINE (PD-158780), A POTENT AND SPECIFIC INHIBITOR OF THE TYROSINE KINASE-ACTIVITY OF RECEPTORS FOR THE EGF FAMILY OF GROWTH-FACTORS, Journal of medicinal chemistry, 41(5), 1998, pp. 742-751
Authors:
KLUTCHKO SR
HAMBY JM
BOSCHELLI DH
WU ZP
KRAKER AJ
AMAR AM
HARTL BG
SHEN C
KLOHS WD
STEINKAMPF RW
DRISCOLL DL
NELSON JM
ELLIOTT WL
ROBERTS BJ
STONER CL
VINCENT PW
DYKES DJ
PANEK RL
LU GH
MAJOR TC
DAHRING TK
HALLAK H
BRADFORD LA
SHOWALTER HDH
DOHERTY AM
Citation: Sr. Klutchko et al., 2-SUBSTITUTED AMINOPYRIDO[2,3-D]PYRIMIDIN-7(8H) ONES - STRUCTURE-ACTIVITY-RELATIONSHIPS AGAINST SELECTED TYROSINE KINASES AND IN-VITRO AND IN-VIVO ANTICANCER ACTIVITY, Journal of medicinal chemistry, 41(17), 1998, pp. 3276-3292
Authors:
SMAILL JB
DENNY WA
FRY DW
NELSON JM
LEOPOLD WR
VINCENT PW
PATMORE SJ
ELLIOTT WL
HOOK KE
BRIDGES AJ
ZHOU H
SHOWALTER HDH
MCNAMARA DJ
DOBRUSIN EM
Citation: Jb. Smaill et al., DEVELOPMENT, STRUCTURE-ACTIVITY-RELATIONSHIPS AND ANTITUMOR-ACTIVITY OF A NOVEL CLASS OF SPECIFIC, IRREVERSIBLE EGFR TK INHIBITORS, British Journal of Cancer, 78, 1998, pp. 34-34
Authors:
VINCENT PW
ROBERTS BJ
ELLIOTT WL
LEOPOLD WR
Citation: Pw. Vincent et al., CHEMOTHERAPY WITH DMXAA (5,6-DIMETHYLXANTHENONE-4-ACETIC ACID) IN COMBINATION WITH CI-1010 ROMOETHYL)AMINO]METHYL]-2-NITRO-,MONO-HYDROBROMIDE (R-ISOMER)) AGAINST ADVANCED-STAGE MURINE COLON-CARCINOMA-26, Oncology Reports, 4(1), 1997, pp. 143-147
Authors:
SHOWALTER HDH
SERCEL AD
LEJA BM
WOLFANGEL CD
AMBROSO LA
ELLIOTT WL
FRY DW
KRAKER AJ
HOWARD CT
LU GH
MOORE CW
NELSON JM
ROBERTS BJ
VINCENT PW
DENNY WA
THOMPSON AM
Citation: Hdh. Showalter et al., TYROSINE KINASE INHIBITORS .6. STRUCTURE-ACTIVITY-RELATIONSHIPS AMONGN-SUBSTITUTED AND 3-SUBSTITUTED 2,2'-DISELENOBIS(1H-INDOLES) FOR INHIBITION OF PROTEIN-TYROSINE KINASES AND COMPARATIVE IN-VITRO AND IN-VIVO STUDIES AGAINST SELECTED SULFUR CONGENERS, Journal of medicinal chemistry, 40(4), 1997, pp. 413-426
Authors:
THOMPSON AM
MURRAY DK
ELLIOTT WL
FRY DW
NELSON JA
SHOWALTER HDH
ROBERTS BJ
VINCENT PW
DENNY WA
Citation: Am. Thompson et al., TYROSINE KINASE INHIBITORS .13. STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SOLUBLE 7-SUBSTITUTED 4-[(3-BROMOPHENYL)AMINO]PYRIDO[4,3-D]PYRIMIDINESDESIGNED AS INHIBITORS OF THE TYROSINE KINASE-ACTIVITY OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, Journal of medicinal chemistry, 40(24), 1997, pp. 3915-3925
Authors:
ELLIOTT WL
HOWARD CT
ROBERTS BJ
HOOK KE
VINCENT PW
CORBETT TH
LEOPOLD WR
Citation: Wl. Elliott et al., ENHANCED THERAPEUTIC EFFECT OF AMSALOG (CI-921) IN COMBINATION WITH CISPLATIN IN-VITRO AND IN-VIVO, Oncology Reports, 3(6), 1996, pp. 1153-1159